Leslie Delaney
Ridgeland, MSNPI 1982715454
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 140 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by Tris Pharma Inc at 24.6% of the total.
Across 140 payments — averaging $18.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Tris Pharma Inc$623
- Sanofi Pasteur Inc.$349
- Pfizer$297
- Takeda Pharmaceuticals U.S.A., Inc.$283
- GSK$212
- Ironshore Pharmaceuticals Inc.$209
- plus $558 from 11 others
What the payments were for
- Food & beverage$2,531100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Tris Pharma Inc | 34 | $623 |
| Sanofi Pasteur Inc. | 12 | $349 |
| Pfizer | 17 | $297 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $283 |
| GSK | 15 | $212 |
| Ironshore Pharmaceuticals Inc. | 12 | $209 |
| Merck | 11 | $187 |
| Corium, LLC | 7 | $135 |
| Collegium Pharmaceutical, Inc. | 3 | $55 |
| AbbVie(2 entities) | 2 | $39 |
| Arbor Pharmaceuticals, Inc. | 3 | $38 |
| Seqirus USA Inc | 2 | $29 |
| Supernus Pharmaceuticals, Inc. | 1 | $21 |
| Genentech USA, Inc. | 1 | $18 |
| Neos Therapeutics, LP | 1 | $13 |
| Mission Pharmacal Company | 1 | $12 |
| Almirall LLC | 1 | $11 |
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.